Human LIFR Recombinant (CD118) from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
Human LIFR Recombinant (CD118)

Get Pricing

Description

LIF acts on its target cells via the activation of the LIF-receptor (LIFR) complex. The LIFR complex requires heterodimerisation of the two low affinity components LIFR and glycoprotein 130 (gp130), where combination transforms a low-affinity binding complex into a high- affinity binding site. Activation of the LIFR complex can trigger several signal transduction paIn LIF-induced heterodimerization with the LIFR, only the CBM of gp130 contacts LIF. The LIFR contributes mainly with its Ig-like domain to LIF binding